$882 Million is the total value of Bronte Capital Management Pty Ltd.'s 17 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 13.3% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRcall | $218,499,000 | +268.8% | 98,400 | +228.0% | 24.78% | +164.7% |
| BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $109,266,000 | -4.1% | 427,704 | -13.0% | 12.39% | -31.2% |
| GOOGL | Buy | ALPHABET INCcap stk cl a | $100,018,000 | +353.6% | 48,493 | +285.3% | 11.34% | +225.6% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $94,068,000 | -5.0% | 2,120,559 | +2.9% | 10.67% | -31.8% |
| IBKR | Sell | INTERACTIVE BROKERS GROUP | $62,373,000 | -20.6% | 853,951 | -33.8% | 7.08% | -43.0% |
| IWO | New | ISHARES TRcall | $52,630,000 | – | 175,000 | +100.0% | 5.97% | – |
| V | Sell | VISA INC | $44,328,000 | -35.1% | 209,360 | -33.0% | 5.03% | -53.4% |
| SPY | Sell | SPDR S&P 500 ETF TRcall | $39,332,000 | -30.2% | 9,900 | -34.0% | 4.46% | -49.9% |
| CTVA | Sell | CORTEVA NC | $38,445,000 | +18.8% | 824,656 | -1.3% | 4.36% | -14.7% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $28,098,000 | +205.2% | 59,387 | +211.7% | 3.19% | +119.2% |
| BK | Buy | BANK NEW YORK MELLON CORP | $23,582,000 | +15.7% | 498,663 | +3.8% | 2.68% | -17.0% |
| STT | Buy | STATE STR CORP | $22,597,000 | +17.8% | 268,980 | +2.1% | 2.56% | -15.4% |
| MO | New | ALTRIA GROUP INC | $14,729,000 | – | 287,909 | +100.0% | 1.67% | – |
| GOOG | Sell | ALPHABET INCcap stk cl c | $14,464,000 | -38.4% | 6,992 | -51.7% | 1.64% | -55.8% |
| NEM | Sell | NEWMONT CORP | $7,921,000 | -60.1% | 131,430 | -60.4% | 0.90% | -71.4% |
| GHC | Buy | GRAHAM HLDGS CO | $7,841,000 | +8.2% | 13,941 | +2.6% | 0.89% | -22.4% |
| MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $3,458,000 | -5.6% | 550,679 | +3.6% | 0.39% | -32.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-04-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.